In Good Company

Could AstraZeneca CEO Pascal Soriot help you live to 200?

After leading AstraZeneca to a spectacular turnaround, CEO Pascal Soriot is guiding it to the cutting edge of medical research

CEO Pascal Soriot led AstraZeneca to play a stellar role in helping tackle the pandemic by making its Vaxzevria vaccine available at no profit or at cost. ST PHOTO: FELINE LIM
New: Gift this subscriber-only story to your friends and family

Talk about crowning glory!

On June 1, when his name appeared in the Queen's birthday honours list for a knighthood, Mr Pascal Soriot was preparing to mark a decade at the helm of AstraZeneca (AZ), the Cambridge, UK-based biopharmaceuticals company where he orchestrated one of the world's great turnaround stories.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.